top of page
Paper #2.jpg

Search Results

43 results found for "biotech strategy consulting"

  • Collaboration in Biotech Fails When Science and Strategy Disconnect

    👉 Most biotech founders believe in collaboration in biotech. You can usually recognize healthy collaboration in biotech by a few clear patterns. 👉 Strong teams consistently Strategic takeaway - Collaboration is a strategic choice 👉 Collaboration in biotech is not a cultural Attila runs focused strategy consultations for biotech founders  who are ready to lead with clarity, making tough tradeoffs, or simply feeling stuck, this session will get you unstuck — fast. 👉 Book a 1:1 consult

  • Biotech Licensing Strategy: The Hidden Terms That Scare Investors

    It shows up when founders treat biotech licensing like a moment of validation instead of a strategic A Simple Framework: The Three Levers of Licensing Strategy Think of your licensing agreement as three Strategic Takeaway – Clean Biotech Licensing 👉 The hard truth: Investors don’t just invest in science Attila runs focused strategy consultations for biotech founders who are ready to lead with clarity, not trade-offs, or simply feeling stuck, this session will help you get unstuck quickly. 👉 Book a 1:1 consult

  • Biotech Startups Are Overestimating AI and Underestimating Strategy

    The AI Buzz Is Real But So Is the Strategy Gap 👉 AI is dominating the biotech conversation right now in biotech . 👉 In biotech, strategy is not optional. Attila runs focused strategy consultations for biotech founders  who are ready to lead with clarity, making tough tradeoffs, or simply feeling stuck, this session will get you unstuck — fast. 👉 Book a 1:1 consult

  • Clarity Beats Certainty: The Strategy Advantage in Early-Stage Biotech

    Strategy Advantage: Why Clarity Wins This is where the strategy advantage  becomes clear. Clarity Is Strategic If you’re building an early-stage biotech company, stop chasing the illusion of That’s what strategy is. Attila runs focused strategy consultations for biotech founders  who are ready to lead with clarity, making tough tradeoffs, or simply feeling stuck, this session will get you unstuck — fast. 👉 Book a 1:1 consult

  • Strategy Before Tactics: The Step Most Biotech Startups Skip

    Biotech startups often jump into tactics without a clear strategy. Why Biotech Startups Treat Strategy as Optional In the early stages, many biotech founders convince themselves Biotech innovation is powerful, but without strategy it’s just scattered light. Attila runs focused strategy consultations for biotech founders  who are ready to lead with clarity, making tough tradeoffs, or simply feeling stuck, this session will get you unstuck — fast. 👉 Book a 1:1 consult

  • From Delegation to Strategy: The Hidden Key to Scaling Biotech Startups

    Strategic delegation turns individual efforts into a system that drives biotech growth. Treating it as a strategy will unlock a path to scale. This is why scaling biotech startups depends on strategic role alignment.   Attila runs focused strategy consultations for biotech founders  who are ready to lead with clarity, making tough tradeoffs, or simply feeling stuck, this session will get you unstuck — fast. 👉 Book a 1:1 consult

  • AI in Biotech Strategy: Cutting Through the Hype to What Actually Matters

    "AI in biotech strategy: Use it as a tool, not a crutch" The Reality of AI in Biotech Strategy Let’s “AI in biotech strategy only creates value when it's aligned with your scientific and business milestones But unless you’ve anchored your biotech strategy in a real-world problem — a patient need, a technical Attila runs focused strategy consultations for biotech founders  who are ready to lead with clarity, making tough tradeoffs, or simply feeling stuck, this session will get you unstuck — fast. 👉 Book a 1:1 consult

  • Biotech Ethics Strategy: How Founders Turn Responsibility Into a Competitive Advantage

    . ✅ That’s where a biotech ethics strategy  becomes more than a nice-to-have. Why a Biotech Ethics Strategy Matters More Than Ever The biotech industry is evolving faster than regulation How to Build a Biotech Ethics Strategy That Drives Growth Treat ethics like any other strategic pillar Attila runs focused strategy consultations for biotech founders  who are ready to lead with clarity, making tough tradeoffs, or simply feeling stuck, this session will get you unstuck — fast. 👉 Book a 1:1 consult

  • From Mirror to Market: The Shift Every Biotech Growth Strategy Needs to Succeed

    Strategy gives your biotech science a destination. Without it, progress stays in the lab. But underneath the surface, your biotech growth strategy is drifting off course. "   👉 When you adopt this lens early, your biotech growth strategy becomes coherent. Attila runs focused strategy consultations for biotech founders  who are ready to lead with clarity, making tough tradeoffs, or simply feeling stuck, this session will get you unstuck — fast. 👉 Book a 1:1 consult

  • The Strategic Blueprint: Turning Biotech Ideas Into Scalable Companies

    You’ll discover: Why strategy is as critical as science  in biotech success Which systems and processes What Is Strategy—And Why Do Most Biotech Founders Get It Wrong? From Understanding to Action: How to Build a Strategic, Systematic Biotech Company Knowing what strategy Attila runs focused strategy consultations for biotech founders  who are ready to lead with clarity, making tough tradeoffs, or simply feeling stuck, this session will get you unstuck — fast. 👉 Book a 1:1 consult

  • Escaping the Science Trap: A Real Biotech Commercialization Strategy for Founders

    Most biotech startups get stuck proving potential. , traction-focused biotech commercialization strategy looks like, without hiring a whole BD team or What a Real Biotech Commercialization Strategy Looks Like Most biotech founders think commercialization Attila runs focused strategy consultations for biotech founders  who are ready to lead with clarity, making tough tradeoffs, or simply feeling stuck, this session will get you unstuck — fast. 👉 Book a 1:1 consult

  • Why Patent Strategy Review Is the First Thing Smart Biotech CEOs Revisit Each Year

    A thoughtful patent strategy review early in the year allows biotech CEOs to realign intellectual property Turning Patent Strategy Review Into a Leadership Habit For many biotech companies, patent discussions Smart biotech CEOs understand that strategy is not a document. Attila runs focused strategy consultations for biotech founders who are ready to lead with clarity, not trade-offs, or simply feeling stuck, this session will help you get unstuck quickly. 👉 Book a 1:1 consult

bottom of page